Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patient. Far beyond mineral bone disease regulation Laura Salanova Villanueva; Yohana Gil Giraldo; Begoña Santos Sánchez-Rey; Abelardo Aguilera Peralta;

RIPK3 and kidney disease Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease Jose Luis Górriz; José Ramón González-Juanatey; Lorenzo Facila; Maria Jose Soler; Alfonso Valle; Alberto Ortiz;